Ticagrelor and central sleep apnoea: Impact of withdrawal and reintroduction
- PMID: 31206207
- PMCID: PMC6624382
- DOI: 10.1111/bcp.13967
Ticagrelor and central sleep apnoea: Impact of withdrawal and reintroduction
Conflict of interest statement
There are no competing interests to declare.
Figures



References
-
- Giannoni A, Emdin M, Passino C. Cheyne‐stokes respiration, chemoreflex, and ticagrelor‐related dyspnea. N Engl J Med. 2016;375(10):1004‐1006. - PubMed
-
- Wallentin L, Becker RC, Budaj A, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009;361(11):1045‐1057. - PubMed
-
- Lamberts V, Baele P, Kahn D, Listro G. Dyspnea or Cheyne‐Stokes respiration associated with Ticagrelor? Sleep Med. 2018;43:4‐6. - PubMed
-
- Conte L, Pugliese NR, Giannoni A. Reversal of ticagrelor induced arrhythmias and Cheyne‐Stokes respiration with aminophylline infusion. J Cardiovasc Pharmacol. 2017;70(5):290‐292. - PubMed
-
- Hetzenecker A, Buchner S, Greimel T, et al. Cardiac workload in patients with sleep‐disordered breathing early after acute myocardial infarction. Chest. 2013;143(5):1294‐1301. - PubMed